首页> 外国专利> METHOD OF DETERMINING PRESCRIPTION OF CHRONIC SUBDURAL HEMATOMAS

METHOD OF DETERMINING PRESCRIPTION OF CHRONIC SUBDURAL HEMATOMAS

机译:确定慢性硬膜下血肿的处方的方法

摘要

FIELD: medicine.;SUBSTANCE: method is implemented by preparing histological sections of a subdural hematoma capsule, measuring the maximum thickness of the capsule, the relative volume of a capsule hemosiderosis and the relative fraction of macrophages in a cell infiltrate of the subdural hematoma capsules and obtaining a point and interval estimate of prescription of the subdural hematoma with any degree of confidence probability by formula T=5.748+0.012 ℓ + 154.452h+14.487m±7.873tα;40, where T is prescription of the subdural hematoma, days; ℓ is the maximum thickness of the capsule, mcm; h is the relative volume of the capsule hemosiderosis; m is the relative fraction of macrophages in the cell infiltrate of the capsule; tα; 40 is a value of t-criterion with a reliable significance level α and 40 degrees of freedom.;EFFECT: higher accuracy of determining prescription of the chronic subdural hematomas and possibility of obtaining the interval estimates of prescription at any levels of confidence probability.;2 ex
机译:领域:药物;方法:通过制备硬膜下血肿囊的组织学切片,测量胶囊的最大厚度,胶囊铁血黄素沉着病的相对体积以及硬膜下血肿胶囊的细胞浸润中巨噬细胞的相对分数来实施该方法。通过公式T = 5.748 + 0.012ℓ+ 154.452h + 14.487m±7.873t α; 40 获得具有任何置信度的硬膜下血肿处方的点数和区间估计硬膜下血肿的处方,天; ℓ是胶囊的最大厚度,mcm; h是胶囊中铁血黄素沉着症的相对体积; m是巨噬细胞在胶囊细胞浸润中的相对分数; t α; 40 是t准则的值,具有可靠的显着性水平α和40个自由度。;效果:确定慢性硬膜下血肿的处方的准确性更高,并且可以获得在任何水平的硬脑膜下血肿的处方间隔估计的可能性置信概率。; 2 ex

著录项

  • 公开/公告号RU2426120C1

    专利类型

  • 公开/公告日2011-08-10

    原文格式PDF

  • 申请/专利权人 NEDUGOV GERMAN VLADIMIROVICH;

    申请/专利号RU20100127697

  • 发明设计人 NEDUGOV GERMAN VLADIMIROVICH;

    申请日2010-07-05

  • 分类号G01N33/48;

  • 国家 RU

  • 入库时间 2022-08-21 17:48:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号